Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 1998

View Archived Issues

Hypoglycemic effects of the alpha2-adrenoceptor antagonists SL-84.0418 and deriglidole

T-794: a MAO-A inhibitor with antidepressant activity

Evaluation of combination therapy for the treatment of erectile dysfunction

Effects of aspirin + ticlopidine combination antiplatelet therapy following stent implantation

Genentech: Q1 1998 highlights

Idun seeks licensing partners for apoptosis regulators

Sertraline: a selective serotonin reuptake inhibitor for the treatment of PMDD

New endothelin antagonists from Bristol-Myers Squibb

Synthetic dolastatin derivatives as antitumor agents

Akorn acquires ophthalmic products from Alza

Company Profile: Ixion Biotechnology

Fujisawa-Fisons to promote respiratory product in Japan

Alza acquires Canadian rights to Ditropan

Schering-Plough seeks FDA approval for Intron A combination

COX-2 inhibitors claimed by AHP for arthritis, cancer and AD

Novel cell adhesion inhibitors discovered at Biogen

Chiesi prepares new anticonvulsants and neuroprotective agents

P&U claims new distamycin derivatives and their use as antitumor and antiviral agents

Conjugates for imaging vascular thrombi developed at NeoRx/U. of Washington

First launch for topical biologic that helps heal diabetic foot ulcers

Potential preventive HIV vaccine shows promise in preclinical studies

RPR's Gliadel Wafer approved in Argentina

Abbott acquires control of Murex, as previously agreed

Provid Research: new Praecis chemistry division

Cardiovascular gene therapy focus of Cell Genesys-Mitotix agreement

New data confirms efficacy of Zomig

SWR-0035: new beta3-adrenoceptor agonist introduced at Japanese meeting

Fujisawa develops compound with submicromolar activity against H. pylori

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...